In brief: GTG, Resonance Health, Sirtex
Thursday, 07 July, 2005
Genetic Technologies (ASX:GTG) has settled all of its disputes with the Auckland District Health Board, as the representative of all the New Zealand district health boards plus the New Zealand Blood Service. The disputes related to lawsuits filed in New Zealand in 2004 by ADHB against Genetic Technologies' non-coding DNA analysis patent and genomic mapping patent.
Resonance Health (ASX:RHT) has expanded its Medical Advisory Board with new members Dr Bruce Bacon, Dr John Olynyk and Dr John Porter joining current member Dr Kris Kowdley. Dr Chris Bennett has resigned from her position on the former Inner Vision Biometrics Medical Advisory Board but remains as a non-executive director of Resonance Health.
Sirtex Medical (ASX:SRX) has appointed Angela Talbot as its chief financial officer.
Link between oestrogen and heart health found in women
Scientists found that oestrogen helps increase the ANXA1 protein, and when ANXA1 is missing, the...
Frequent nightmares accelerate aging, increase risk of death
Nghtmares independently predict faster biological aging and earlier mortality — even after...
Cardiac organoids bring hope for treating heart disease
Australian scientists have developed lab-grown, three-dimensional heart tissues known as cardiac...
